Orforglipron, an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant interest since emerging as a research candidate
The addition of an acetyl group at the N-terminus enhances its stability, potency, and ability to cross the blood-brain barrier
The Potential Health Benefits of Liposomal Glutathione* Glutathione is one of the most abundant intracellular molecules in the body
Well our physician-supervised semaglutide program helps control appetite, burn fat, and deliver real, sustainable results
Yes, the FDAs black box warning for medullary thyroid carcinoma and MEN 2 syndrome applies to the entire class of GLP-1 receptor agonists, which include liraglutide (Saxeda and Victoza), dulaglutide (Trulicity), semaglutide (Ozempic, Rybelsus, and Wegovy), and tirzepatide (Mounjaro and Zepbound)